Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,973 | -9,344 | -4,815 | 21,591 | 9,323 |
| Depreciation Amortization | 8,683 | 5,805 | 2,897 | 11,519 | 8,630 |
| Accounts receivable | -6,685 | 19,805 | 23,143 | -8,368 | 10,862 |
| Accounts payable and accrued liabilities | 620 | 6,611 | 2,075 | 449 | -1,379 |
| Other Working Capital | -2,717 | 11,446 | 10,677 | -17,854 | -10,353 |
| Other Operating Activity | 12,437 | -22,050 | -22,731 | 19,672 | -529 |
| Operating Cash Flow | $23,311 | $12,273 | $11,246 | $27,009 | $16,554 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -20 | N/A | -140 | -95 |
| Purchase Of Investment | -60,956 | -44,892 | -24,974 | -23,813 | -12,511 |
| Sale Of Investment | 42,878 | 26,535 | 5,894 | 17,328 | 14,151 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -12,500 | -12,500 |
| Other Investing Activity | 0 | 0 | 0 | -12,500 | -12,500 |
| Investing Cash Flow | $-18,118 | $-18,377 | $-19,080 | $-19,125 | $-10,955 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22,220 | -11,110 | N/A | N/A | N/A |
| Common Stock Issued | 150 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -445 | -222 | 0 | 0 | 0 |
| Financing Cash Flow | $-22,515 | $-11,332 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 86,676 | 86,676 | 86,676 | 78,792 | 78,792 |
| End Cash Position | 69,354 | 69,240 | 78,842 | 86,676 | 84,391 |
| Net Cash Flow | $-17,322 | $-17,436 | $-7,834 | $7,884 | $5,599 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,311 | 12,273 | 11,246 | 27,009 | 16,554 |
| Capital Expenditure | -40 | -20 | N/A | -140 | -95 |
| Free Cash Flow | 23,271 | 12,253 | 11,246 | 26,869 | 16,459 |